nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—Cyanocobalamin—MTHFR—polycystic ovary syndrome	0.0127	1	CrCbGaD
Hydroxocobalamin—MMACHC—endocrine gland—polycystic ovary syndrome	0.0105	0.0289	CbGeAlD
Hydroxocobalamin—MMAB—adrenal cortex—polycystic ovary syndrome	0.0103	0.0284	CbGeAlD
Hydroxocobalamin—CUBN—pituitary gland—polycystic ovary syndrome	0.00937	0.0259	CbGeAlD
Hydroxocobalamin—CUBN—adipose tissue—polycystic ovary syndrome	0.00933	0.0258	CbGeAlD
Hydroxocobalamin—TCN1—endometrium—polycystic ovary syndrome	0.00932	0.0258	CbGeAlD
Hydroxocobalamin—MMAA—adipose tissue—polycystic ovary syndrome	0.00883	0.0244	CbGeAlD
Hydroxocobalamin—CUBN—adrenal gland—polycystic ovary syndrome	0.00837	0.0231	CbGeAlD
Hydroxocobalamin—MMAB—pituitary gland—polycystic ovary syndrome	0.00831	0.023	CbGeAlD
Hydroxocobalamin—MMAB—adipose tissue—polycystic ovary syndrome	0.00828	0.0229	CbGeAlD
Hydroxocobalamin—MMAA—adrenal gland—polycystic ovary syndrome	0.00792	0.0219	CbGeAlD
Hydroxocobalamin—CUBN—female gonad—polycystic ovary syndrome	0.00781	0.0216	CbGeAlD
Hydroxocobalamin—CASP9—adipose tissue—polycystic ovary syndrome	0.00773	0.0214	CbGeAlD
Hydroxocobalamin—TCN2—pituitary gland—polycystic ovary syndrome	0.00758	0.0209	CbGeAlD
Hydroxocobalamin—TCN2—adipose tissue—polycystic ovary syndrome	0.00755	0.0208	CbGeAlD
Hydroxocobalamin—MMAB—adrenal gland—polycystic ovary syndrome	0.00743	0.0205	CbGeAlD
Hydroxocobalamin—MMAA—female gonad—polycystic ovary syndrome	0.00738	0.0204	CbGeAlD
Hydroxocobalamin—MUT—adrenal cortex—polycystic ovary syndrome	0.00738	0.0204	CbGeAlD
Hydroxocobalamin—MMAA—vagina—polycystic ovary syndrome	0.00734	0.0203	CbGeAlD
Hydroxocobalamin—CUBN—endocrine gland—polycystic ovary syndrome	0.00726	0.0201	CbGeAlD
Hydroxocobalamin—TCN1—vagina—polycystic ovary syndrome	0.00699	0.0193	CbGeAlD
Hydroxocobalamin—CASP9—adrenal gland—polycystic ovary syndrome	0.00694	0.0192	CbGeAlD
Hydroxocobalamin—MMAB—female gonad—polycystic ovary syndrome	0.00692	0.0191	CbGeAlD
Hydroxocobalamin—MMAB—vagina—polycystic ovary syndrome	0.00688	0.019	CbGeAlD
Hydroxocobalamin—MMAA—endocrine gland—polycystic ovary syndrome	0.00687	0.019	CbGeAlD
Hydroxocobalamin—TCN2—adrenal gland—polycystic ovary syndrome	0.00677	0.0187	CbGeAlD
Hydroxocobalamin—MTRR—adrenal cortex—polycystic ovary syndrome	0.00663	0.0183	CbGeAlD
Hydroxocobalamin—MUT—endometrium—polycystic ovary syndrome	0.00659	0.0182	CbGeAlD
Hydroxocobalamin—CASP9—female gonad—polycystic ovary syndrome	0.00647	0.0179	CbGeAlD
Hydroxocobalamin—MMAB—endocrine gland—polycystic ovary syndrome	0.00644	0.0178	CbGeAlD
Hydroxocobalamin—CASP9—vagina—polycystic ovary syndrome	0.00643	0.0178	CbGeAlD
Hydroxocobalamin—MUT—uterus—polycystic ovary syndrome	0.00607	0.0168	CbGeAlD
Hydroxocobalamin—CASP9—endocrine gland—polycystic ovary syndrome	0.00602	0.0166	CbGeAlD
Hydroxocobalamin—MUT—pituitary gland—polycystic ovary syndrome	0.00596	0.0165	CbGeAlD
Hydroxocobalamin—MUT—adipose tissue—polycystic ovary syndrome	0.00594	0.0164	CbGeAlD
Hydroxocobalamin—MTRR—endometrium—polycystic ovary syndrome	0.00592	0.0163	CbGeAlD
Hydroxocobalamin—TCN2—endocrine gland—polycystic ovary syndrome	0.00587	0.0162	CbGeAlD
Hydroxocobalamin—MTR—adrenal cortex—polycystic ovary syndrome	0.00578	0.016	CbGeAlD
Hydroxocobalamin—MTRR—uterus—polycystic ovary syndrome	0.00545	0.0151	CbGeAlD
Hydroxocobalamin—MTRR—pituitary gland—polycystic ovary syndrome	0.00536	0.0148	CbGeAlD
Hydroxocobalamin—MTRR—adipose tissue—polycystic ovary syndrome	0.00533	0.0147	CbGeAlD
Hydroxocobalamin—MUT—adrenal gland—polycystic ovary syndrome	0.00532	0.0147	CbGeAlD
Hydroxocobalamin—MTR—endometrium—polycystic ovary syndrome	0.00516	0.0143	CbGeAlD
Hydroxocobalamin—MUT—female gonad—polycystic ovary syndrome	0.00496	0.0137	CbGeAlD
Hydroxocobalamin—MUT—vagina—polycystic ovary syndrome	0.00493	0.0136	CbGeAlD
Hydroxocobalamin—MTRR—adrenal gland—polycystic ovary syndrome	0.00478	0.0132	CbGeAlD
Hydroxocobalamin—MTR—uterus—polycystic ovary syndrome	0.00476	0.0131	CbGeAlD
Hydroxocobalamin—MTR—pituitary gland—polycystic ovary syndrome	0.00467	0.0129	CbGeAlD
Hydroxocobalamin—MTR—adipose tissue—polycystic ovary syndrome	0.00465	0.0128	CbGeAlD
Hydroxocobalamin—MUT—endocrine gland—polycystic ovary syndrome	0.00462	0.0128	CbGeAlD
Hydroxocobalamin—MTRR—female gonad—polycystic ovary syndrome	0.00446	0.0123	CbGeAlD
Hydroxocobalamin—MTRR—vagina—polycystic ovary syndrome	0.00443	0.0122	CbGeAlD
Hydroxocobalamin—MTR—adrenal gland—polycystic ovary syndrome	0.00417	0.0115	CbGeAlD
Hydroxocobalamin—MTRR—endocrine gland—polycystic ovary syndrome	0.00415	0.0115	CbGeAlD
Hydroxocobalamin—MTR—female gonad—polycystic ovary syndrome	0.00389	0.0107	CbGeAlD
Hydroxocobalamin—MTR—vagina—polycystic ovary syndrome	0.00387	0.0107	CbGeAlD
Hydroxocobalamin—MTR—endocrine gland—polycystic ovary syndrome	0.00362	0.00999	CbGeAlD
Hydroxocobalamin—Chest discomfort—Metformin—polycystic ovary syndrome	0.000726	0.0953	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000387	0.0507	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000318	0.0417	CcSEcCtD
Hydroxocobalamin—Eye disorder—Metformin—polycystic ovary syndrome	0.000302	0.0396	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0003	0.0393	CcSEcCtD
Hydroxocobalamin—Angiopathy—Metformin—polycystic ovary syndrome	0.000293	0.0384	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Metformin—polycystic ovary syndrome	0.000292	0.0382	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000291	0.0381	CcSEcCtD
Hydroxocobalamin—Chills—Metformin—polycystic ovary syndrome	0.00029	0.038	CcSEcCtD
Hydroxocobalamin—Erythema—Metformin—polycystic ovary syndrome	0.000281	0.0368	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000261	0.0342	CcSEcCtD
Hydroxocobalamin—Malaise—Metformin—polycystic ovary syndrome	0.000253	0.0332	CcSEcCtD
Hydroxocobalamin—Chest pain—Metformin—polycystic ovary syndrome	0.000239	0.0314	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000238	0.0312	CcSEcCtD
Hydroxocobalamin—Discomfort—Metformin—polycystic ovary syndrome	0.000236	0.031	CcSEcCtD
Hydroxocobalamin—Oedema—Metformin—polycystic ovary syndrome	0.000229	0.0301	CcSEcCtD
Hydroxocobalamin—Infection—Metformin—polycystic ovary syndrome	0.000228	0.0299	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000225	0.0295	CcSEcCtD
Hydroxocobalamin—Skin disorder—Metformin—polycystic ovary syndrome	0.000223	0.0292	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000204	0.0268	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000202	0.0265	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000198	0.026	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000189	0.0248	CcSEcCtD
Hydroxocobalamin—Urticaria—Metformin—polycystic ovary syndrome	0.000182	0.0239	CcSEcCtD
Hydroxocobalamin—Pruritus—Metformin—polycystic ovary syndrome	0.000162	0.0213	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000157	0.0206	CcSEcCtD
Hydroxocobalamin—Dizziness—Metformin—polycystic ovary syndrome	0.000152	0.0199	CcSEcCtD
Hydroxocobalamin—Rash—Metformin—polycystic ovary syndrome	0.000145	0.019	CcSEcCtD
Hydroxocobalamin—Dermatitis—Metformin—polycystic ovary syndrome	0.000144	0.0189	CcSEcCtD
Hydroxocobalamin—Headache—Metformin—polycystic ovary syndrome	0.000144	0.0188	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000138	0.000224	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKR1C3—polycystic ovary syndrome	0.000138	0.000223	CbGpPWpGaD
Hydroxocobalamin—Nausea—Metformin—polycystic ovary syndrome	0.000136	0.0179	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—SLC2A4—polycystic ovary syndrome	0.000136	0.00022	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CYP17A1—polycystic ovary syndrome	0.000135	0.000219	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT2—polycystic ovary syndrome	0.000135	0.000218	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—MTHFR—polycystic ovary syndrome	0.000134	0.000218	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—MTHFR—polycystic ovary syndrome	0.000134	0.000218	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000134	0.000218	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SULT2A1—polycystic ovary syndrome	0.000134	0.000217	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000134	0.000217	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKR1C3—polycystic ovary syndrome	0.000134	0.000217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000134	0.000216	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IRS1—polycystic ovary syndrome	0.000133	0.000216	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IRS1—polycystic ovary syndrome	0.000133	0.000216	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MTHFR—polycystic ovary syndrome	0.000133	0.000215	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MTHFR—polycystic ovary syndrome	0.000133	0.000215	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NCOR1—polycystic ovary syndrome	0.000132	0.000214	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GNAS—polycystic ovary syndrome	0.000132	0.000214	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—GNAS—polycystic ovary syndrome	0.000132	0.000214	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TNRC6B—polycystic ovary syndrome	0.000132	0.000213	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGF18—polycystic ovary syndrome	0.000132	0.000213	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000131	0.000212	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKR1C1—polycystic ovary syndrome	0.000131	0.000212	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CYP19A1—polycystic ovary syndrome	0.00013	0.000211	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRG1—polycystic ovary syndrome	0.00013	0.000211	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PRL—polycystic ovary syndrome	0.00013	0.00021	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—RRM2—polycystic ovary syndrome	0.00013	0.00021	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—SERPINE1—polycystic ovary syndrome	0.000128	0.000208	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—INS—polycystic ovary syndrome	0.000128	0.000207	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—INS—polycystic ovary syndrome	0.000128	0.000207	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MTHFR—polycystic ovary syndrome	0.000127	0.000205	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IRS2—polycystic ovary syndrome	0.000127	0.000205	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IRS2—polycystic ovary syndrome	0.000127	0.000205	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GNAS—polycystic ovary syndrome	0.000126	0.000204	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—NCOR1—polycystic ovary syndrome	0.000126	0.000204	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—NCOR1—polycystic ovary syndrome	0.000126	0.000204	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—YAP1—polycystic ovary syndrome	0.000125	0.000203	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—MTHFR—polycystic ovary syndrome	0.000125	0.000202	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IRS1—polycystic ovary syndrome	0.000124	0.000201	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT2—polycystic ovary syndrome	0.000123	0.0002	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT2—polycystic ovary syndrome	0.000123	0.0002	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000122	0.000198	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRG1—polycystic ovary syndrome	0.000122	0.000197	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGF18—polycystic ovary syndrome	0.000122	0.000197	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IRS2—polycystic ovary syndrome	0.000121	0.000195	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RBP4—polycystic ovary syndrome	0.00012	0.000195	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—NCOR1—polycystic ovary syndrome	0.00012	0.000195	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NAMPT—polycystic ovary syndrome	0.00012	0.000195	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—GAB1—polycystic ovary syndrome	0.00012	0.000195	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000119	0.000193	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CYP1A1—polycystic ovary syndrome	0.000119	0.000193	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PPARG—polycystic ovary syndrome	0.000119	0.000193	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP11A1—polycystic ovary syndrome	0.000119	0.000192	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—INS—polycystic ovary syndrome	0.000119	0.000192	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—IL6—polycystic ovary syndrome	0.000118	0.000191	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—POMC—polycystic ovary syndrome	0.000118	0.00019	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—SERPINE1—polycystic ovary syndrome	0.000117	0.00019	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—SERPINE1—polycystic ovary syndrome	0.000117	0.00019	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—TH—polycystic ovary syndrome	0.000117	0.00019	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MTHFR—polycystic ovary syndrome	0.000117	0.00019	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRG1—polycystic ovary syndrome	0.000117	0.000189	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—INS—polycystic ovary syndrome	0.000117	0.000189	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GNAS—polycystic ovary syndrome	0.000116	0.000189	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT2—polycystic ovary syndrome	0.000115	0.000186	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—SLC2A4—polycystic ovary syndrome	0.000114	0.000185	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—CYP1A1—polycystic ovary syndrome	0.000114	0.000185	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TCF7L2—polycystic ovary syndrome	0.000113	0.000183	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—IL6—polycystic ovary syndrome	0.000113	0.000182	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKR1C3—polycystic ovary syndrome	0.000112	0.000182	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IRS2—polycystic ovary syndrome	0.000111	0.00018	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—MTHFR—polycystic ovary syndrome	0.000111	0.00018	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—MTHFR—polycystic ovary syndrome	0.000111	0.00018	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000111	0.00018	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—GAB1—polycystic ovary syndrome	0.000111	0.00018	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—NCOR1—polycystic ovary syndrome	0.000111	0.00018	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SLC2A4—polycystic ovary syndrome	0.000111	0.00018	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—IL6—polycystic ovary syndrome	0.000111	0.000179	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IRS1—polycystic ovary syndrome	0.00011	0.000179	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IRS1—polycystic ovary syndrome	0.00011	0.000179	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP17A1—polycystic ovary syndrome	0.00011	0.000179	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CAMK2D—polycystic ovary syndrome	0.000109	0.000177	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—SERPINE1—polycystic ovary syndrome	0.000109	0.000176	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PPARG—polycystic ovary syndrome	0.000109	0.000176	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PPARG—polycystic ovary syndrome	0.000109	0.000176	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NCOR1—polycystic ovary syndrome	0.000109	0.000176	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NAMPT—polycystic ovary syndrome	0.000108	0.000175	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—POMC—polycystic ovary syndrome	0.000107	0.000174	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—POMC—polycystic ovary syndrome	0.000107	0.000174	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TNRC6B—polycystic ovary syndrome	0.000107	0.000174	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CYP19A1—polycystic ovary syndrome	0.000107	0.000173	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—INS—polycystic ovary syndrome	0.000107	0.000173	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—INS—polycystic ovary syndrome	0.000107	0.000173	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRG1—polycystic ovary syndrome	0.000107	0.000173	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—MTHFR—polycystic ovary syndrome	0.000106	0.000172	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—IL6—polycystic ovary syndrome	0.000106	0.000171	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PRL—polycystic ovary syndrome	0.000106	0.000171	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—INS—polycystic ovary syndrome	0.000106	0.000171	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—INS—polycystic ovary syndrome	0.000106	0.000171	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IRS1—polycystic ovary syndrome	0.000105	0.000171	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—IL6—polycystic ovary syndrome	0.000105	0.000171	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CYP1A1—polycystic ovary syndrome	0.000105	0.00017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—IL6—polycystic ovary syndrome	0.000105	0.00017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000105	0.000169	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CRP—polycystic ovary syndrome	0.000104	0.000169	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IRS2—polycystic ovary syndrome	0.000104	0.000169	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—IL6—polycystic ovary syndrome	0.000104	0.000169	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT2—polycystic ovary syndrome	0.000102	0.000166	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT2—polycystic ovary syndrome	0.000102	0.000166	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000102	0.000165	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PPARG—polycystic ovary syndrome	0.000101	0.000164	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—INS—polycystic ovary syndrome	0.000101	0.000163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKR1C3—polycystic ovary syndrome	0.000101	0.000163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—IRS2—polycystic ovary syndrome	0.0001	0.000162	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—POMC—polycystic ovary syndrome	9.99e-05	0.000162	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—INS—polycystic ovary syndrome	9.94e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FST—polycystic ovary syndrome	9.92e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TNRC6B—polycystic ovary syndrome	9.92e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—IL6—polycystic ovary syndrome	9.81e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—IL6—polycystic ovary syndrome	9.81e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—IL6—polycystic ovary syndrome	9.81e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—MTHFR—polycystic ovary syndrome	9.81e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRB3—polycystic ovary syndrome	9.8e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT2—polycystic ovary syndrome	9.75e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—IL6—polycystic ovary syndrome	9.73e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IRS1—polycystic ovary syndrome	9.72e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—SERPINE1—polycystic ovary syndrome	9.72e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—SERPINE1—polycystic ovary syndrome	9.72e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LHB—polycystic ovary syndrome	9.69e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—IL6—polycystic ovary syndrome	9.64e-05	0.000156	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTHFR—polycystic ovary syndrome	9.61e-05	0.000156	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—IL6—polycystic ovary syndrome	9.6e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GNAS—polycystic ovary syndrome	9.56e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—TH—polycystic ovary syndrome	9.55e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GNRH1—polycystic ovary syndrome	9.47e-05	0.000153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ATF1—polycystic ovary syndrome	9.44e-05	0.000153	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—INS—polycystic ovary syndrome	9.31e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SLC2A4—polycystic ovary syndrome	9.29e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—SERPINE1—polycystic ovary syndrome	9.27e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKR1C1—polycystic ovary syndrome	9.17e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IRS2—polycystic ovary syndrome	9.15e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IRS1—polycystic ovary syndrome	9.11e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—NCOR1—polycystic ovary syndrome	9.11e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SCT—polycystic ovary syndrome	9.08e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PPARG—polycystic ovary syndrome	9.03e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PPARG—polycystic ovary syndrome	9.03e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT2—polycystic ovary syndrome	9e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—POMC—polycystic ovary syndrome	8.91e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—POMC—polycystic ovary syndrome	8.91e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NCOR1—polycystic ovary syndrome	8.87e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—INS—polycystic ovary syndrome	8.86e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—INS—polycystic ovary syndrome	8.86e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—IRS1—polycystic ovary syndrome	8.75e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP19A1—polycystic ovary syndrome	8.73e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TAB1—polycystic ovary syndrome	8.71e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRG1—polycystic ovary syndrome	8.71e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	8.69e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTNR1B—polycystic ovary syndrome	8.66e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CYP1A1—polycystic ovary syndrome	8.64e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PRL—polycystic ovary syndrome	8.63e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PPARG—polycystic ovary syndrome	8.62e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SERPINE1—polycystic ovary syndrome	8.55e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF18—polycystic ovary syndrome	8.51e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—POMC—polycystic ovary syndrome	8.5e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TCF7L2—polycystic ovary syndrome	8.5e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—INS—polycystic ovary syndrome	8.45e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RBP4—polycystic ovary syndrome	8.44e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT2—polycystic ovary syndrome	8.44e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SLC2A4—polycystic ovary syndrome	8.35e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT2—polycystic ovary syndrome	8.1e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—MTHFR—polycystic ovary syndrome	8.05e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IRS1—polycystic ovary syndrome	7.99e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PRL—polycystic ovary syndrome	7.97e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PPARG—polycystic ovary syndrome	7.95e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—YAP1—polycystic ovary syndrome	7.88e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—POMC—polycystic ovary syndrome	7.84e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTHFR—polycystic ovary syndrome	7.84e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—INS—polycystic ovary syndrome	7.8e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GNAS—polycystic ovary syndrome	7.8e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GAB1—polycystic ovary syndrome	7.77e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—INS—polycystic ovary syndrome	7.65e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IRS2—polycystic ovary syndrome	7.46e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—INSR—polycystic ovary syndrome	7.43e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NCOR1—polycystic ovary syndrome	7.43e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT2—polycystic ovary syndrome	7.39e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—BCL2—polycystic ovary syndrome	7.37e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL18—polycystic ovary syndrome	7.26e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRG1—polycystic ovary syndrome	7.1e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKR1C3—polycystic ovary syndrome	7.06e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP1A1—polycystic ovary syndrome	7.04e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SERPINE1—polycystic ovary syndrome	7.02e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.95e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PGR—polycystic ovary syndrome	6.88e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—polycystic ovary syndrome	6.69e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NCOR1—polycystic ovary syndrome	6.68e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MTHFR—polycystic ovary syndrome	6.56e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRG1—polycystic ovary syndrome	6.55e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—polycystic ovary syndrome	6.53e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IRS1—polycystic ovary syndrome	6.51e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—POMC—polycystic ovary syndrome	6.44e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—INS—polycystic ovary syndrome	6.4e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GHRL—polycystic ovary syndrome	6.39e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLAT—polycystic ovary syndrome	6.39e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—INS—polycystic ovary syndrome	6.23e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ATF1—polycystic ovary syndrome	6.1e-05	9.88e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—polycystic ovary syndrome	6.1e-05	9.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IRS2—polycystic ovary syndrome	6.08e-05	9.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CRP—polycystic ovary syndrome	6.08e-05	9.84e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT2—polycystic ovary syndrome	6.03e-05	9.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.95e-05	9.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—polycystic ovary syndrome	5.9e-05	9.55e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SERPINE1—polycystic ovary syndrome	5.73e-05	9.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NGFR—polycystic ovary syndrome	5.63e-05	9.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IRS2—polycystic ovary syndrome	5.61e-05	9.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRL—polycystic ovary syndrome	5.58e-05	9.03e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—polycystic ovary syndrome	5.58e-05	9.03e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—polycystic ovary syndrome	5.58e-05	9.03e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—polycystic ovary syndrome	5.32e-05	8.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IRS1—polycystic ovary syndrome	5.31e-05	8.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.29e-05	8.57e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—POMC—polycystic ovary syndrome	5.25e-05	8.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—INS—polycystic ovary syndrome	5.22e-05	8.45e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—polycystic ovary syndrome	5.19e-05	8.4e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT2—polycystic ovary syndrome	4.91e-05	7.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GNAS—polycystic ovary syndrome	4.91e-05	7.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IRS1—polycystic ovary syndrome	4.9e-05	7.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—INS—polycystic ovary syndrome	4.69e-05	7.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.68e-05	7.57e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—polycystic ovary syndrome	4.62e-05	7.48e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—polycystic ovary syndrome	4.62e-05	7.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRG1—polycystic ovary syndrome	4.59e-05	7.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT2—polycystic ovary syndrome	4.54e-05	7.34e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—polycystic ovary syndrome	4.41e-05	7.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SERPINE1—polycystic ovary syndrome	4.31e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—polycystic ovary syndrome	4.29e-05	6.95e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—polycystic ovary syndrome	4.07e-05	6.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IRS2—polycystic ovary syndrome	3.93e-05	6.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LEP—polycystic ovary syndrome	3.85e-05	6.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—polycystic ovary syndrome	3.81e-05	6.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IRS1—polycystic ovary syndrome	3.43e-05	5.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—polycystic ovary syndrome	3.34e-05	5.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—POMC—polycystic ovary syndrome	3.3e-05	5.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—INS—polycystic ovary syndrome	3.29e-05	5.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—polycystic ovary syndrome	3.18e-05	5.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT2—polycystic ovary syndrome	3.18e-05	5.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.02e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—polycystic ovary syndrome	2.72e-05	4.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—polycystic ovary syndrome	2.22e-05	3.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.08e-05	3.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—polycystic ovary syndrome	2.05e-05	3.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—polycystic ovary syndrome	1.44e-05	2.33e-05	CbGpPWpGaD
